Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
SLAM DRILLS MORE COPPER MINERALIZATION AT GOODWIN (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Ocular Therapeutix Inc OCUL

Healthcare
Ocular Therapeutix, Inc. is a biopharmaceutical company. The Company is engaged in the development and commercialization of therapies for wet age-related macular degeneration (wet AMD), diabetic retinopathy, and other diseases and conditions of the eye. Its first commercial drug product, DEXTENZA, is for the treatment of ocular inflammation and pain following ophthalmic surgery and ocular... see more

Recent & Breaking News (NDAQ:OCUL)

OCULAR THERAPEUTIX INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing in Ocular Therapeutix, Inc. to Contact The Firm

Business Wire July 10, 2017

INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of Ocular Therapeutix, Inc.

Business Wire July 10, 2017

IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Ocular Therapeutix, Inc. and Encourages Investors with Losses to Contact the Firm

Business Wire July 10, 2017

Block & Leviton Announces Class Action Lawsuit Against Ocular Therapeutix, Inc. (OCUL) And Encourages Shareholders To Contact The Firm

PR Newswire July 10, 2017

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Tahoe Resources Inc. (TAHO) & Lead Plaintiff Deadline: September 5, 2017

PR Newswire July 10, 2017

Block & Leviton LLP Announces Securities Fraud Investigation Of Ocular Therapeutix, Inc. (OCUL) And Encourages Shareholders To Contact The Firm

PR Newswire July 8, 2017

INVESTOR ALERT: Goldberg Law PC Announces the Filing of a Securities Class Action Lawsuit against Tahoe Resources Inc.

Business Wire July 7, 2017

Glancy Prongay & Murray Announces the Filing of a Securities Class Action on Behalf of Ocular Therapeutix, Inc. Investors and Encourages Investors to Contact the Firm

Business Wire July 7, 2017

OCULAR THERAPEUTIX INVESTOR ALERT: Legal Investigation for Potential Securities Law Violations

Business Wire July 7, 2017

IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces an Investigation of Ocular Therapeutix, Inc. and Encourages Investors with Losses to Contact the Firm

Business Wire July 7, 2017

EQUITY ALERT: Rosen Law Firm Files Securities Class Action Lawsuit Against Ocular Therapeutix, Inc. – OCUL

Business Wire July 7, 2017

INVESTOR ALERT: Law Offices of Howard G. Smith Commences Investigation on Behalf of Ocular Therapeutix, Inc. Investors

Business Wire July 7, 2017

IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces an Investigation of Ocular Therapeutix, Inc. and Advises Investors with Losses to Contact the Firm

Business Wire July 7, 2017

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ocular Therapeutix, Inc. -- OCUL

PR Newswire July 7, 2017

INVESTOR ALERT: Goldberg Law PC Announces an Investigation of Ocular Therapeutix, Inc.

Business Wire July 7, 2017

Glancy Prongay & Murray LLP Commences Investigation on Behalf of Ocular Therapeutix, Inc. Investors

Business Wire July 7, 2017

OCULAR THERAPEUTIX INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Ocular Therapeutix, Inc. To Contact The Firm

PR Newswire July 7, 2017

15 Biggest Mid-Day Losers For Friday

Benzinga.com  July 7, 2017

EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Ocular Therapeutix, Inc. – OCUL

Business Wire July 7, 2017

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Concerning Whether the Sale of MRV Communications, Inc. to ADVA Optical Networking is Fair to Shareholders

Business Wire July 7, 2017